Literature DB >> 30500591

Decompressive Hemicraniectomy in the Treatment of Malignant Middle Cerebral Artery Infarction: A Meta-Analysis.

Suparna Das1, Patrick Mitchell2, Nicholas Ross2, Peter C Whitfield3.   

Abstract

BACKGROUND: Malignant middle cerebral artery infarctions are large space-occupying infarctions involving massive edema, herniation, and frequently death. Survivors are disabled. Management involves medical treatment, with or without decompressive hemicraniectomy and later duraplasty. This meta-analysis aimed to determine whether surgery is worthwhile with particular regard to views on quality of life of professionals and patients.
METHODS: A Medline search was performed with the search terms "decompressive surgery," "craniectomy," "hemicraniectomy," "decompressive hemicraniectomy," and "middle cerebral artery," "MCA," "infarct,*" "stroke,*" "embolus," "emboli," "thrombosis," "occlusion," "infarction," and "middle cerebral artery stroke," A second search was also done for views on postoperative quality of life. Studies retrieved were randomized controlled trials, observational studies, and reviews. We compared patients who received only medical treatment with those who had decompressive surgery. Participants were adult patients presenting with malignant middle cerebral artery infarction.
RESULTS: 270 abstracts were reviewed. 40 articles were identified: 8 randomized controlled trials and 4 observational studies. There were a total of 692 patients: 268 surgical and 424 medical. The 2 groups were comparable, with similar demographics. In most trials, mortality was lower with surgery. However, morbidity tended to be higher, particularly in the elderly population. Morbidity was lower with medical treatment. Twelve articles on postoperative quality of life were reviewed; views differed between professionals, and survivors and caregivers. A patient-level comparison could not be made between all studies.
CONCLUSIONS: Surgical decompression results in lowered mortality but high morbidity, especially in the elderly. There is an increase in Quality Adjusted Life Years but at high costs. Professionals think that surgery is not worth the high disability rate. However, patients and caregivers are satisfied with their postoperative quality of life. Survey data from healthy study participants who are not professionals in stroke care were not available. The decision to treat surgically needs to be decided on an individual basis. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decompressive hemicraniectomy; Infarction; Malignant MCA stroke; Middle cerebral artery

Mesh:

Year:  2018        PMID: 30500591     DOI: 10.1016/j.wneu.2018.11.176

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  13 in total

Review 1.  Childhood stroke.

Authors:  Peter B Sporns; Heather J Fullerton; Sarah Lee; Helen Kim; Warren D Lo; Mark T Mackay; Moritz Wildgruber
Journal:  Nat Rev Dis Primers       Date:  2022-02-24       Impact factor: 52.329

2.  Stereotactic Aspiration Acts as an Effective Treatment for Malignant Middle Cerebral Artery Infarction.

Authors:  Zhiyu Wang; Maogang Chen; Chong Wang; Jinbiao Luo; Shujie Sun; Xiangui Lu
Journal:  J Healthc Eng       Date:  2022-04-16       Impact factor: 3.822

Review 3.  BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.

Authors:  Melissa Pergakis; Neeraj Badjatia; Seemant Chaturvedi; Carolyn A Cronin; W Taylor Kimberly; Kevin N Sheth; J Marc Simard
Journal:  Expert Opin Investig Drugs       Date:  2019-10-24       Impact factor: 6.206

Review 4.  Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke.

Authors:  Guillaume Charbonnier; Louise Bonnet; Alessandra Biondi; Thierry Moulin
Journal:  Front Neurol       Date:  2021-02-09       Impact factor: 4.003

5.  Neural Stem Cell Extracellular Vesicles Disrupt Midline Shift Predictive Outcomes in Porcine Ischemic Stroke Model.

Authors:  Samantha E Spellicy; Erin E Kaiser; Michael M Bowler; Brian J Jurgielewicz; Robin L Webb; Franklin D West; Steven L Stice
Journal:  Transl Stroke Res       Date:  2019-12-06       Impact factor: 6.829

Review 6.  Decompressive craniotomy for malignant middle cerebral artery infarction: The quest for an African perspective.

Authors:  Dinesh Naidoo
Journal:  Surg Neurol Int       Date:  2021-05-03

7.  Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial.

Authors:  Leila Dehghani; Arash Khojasteh; Masoud Soleimani; Saeed Oraee-Yazdani; Saeed Heidari Keshel; Mohammad Saadatnia; Masih Saboori; Alireza Zali; Seyed Mahmoud Hashemi; Reyhane Soleimani
Journal:  Int J Prev Med       Date:  2022-01-19

8.  Effect of decompressive hemicraniectomy in patients with acute middle cerebral artery infarction

Authors:  Halil İbrahim Süner; Anıl Tanburoğlu; Emre Durdağ; Soner Çivi; Aylin Güneşli Yetişken; Özgür Kardeş; Çağatay Andiç; Kadir Tufan
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

9.  A Real-World Assessment of Outcomes, Health Resource Utilization, and Costs Associated with Cerebral Edema in US Patients with Large Hemispheric Infarction.

Authors:  Nicole Tsao; Qiang Hou; Shih-Yin Chen; Steven R Messe
Journal:  Pharmacoecon Open       Date:  2021-08-22

10.  Decompressive craniectomy is a life-saving procedure in malignant MCA infarction.

Authors:  Lina Alhumaid; Abdallh Almaneea; Athal Al-Khalaf; Abdullah AlRuwaita; Ahmad AlOraidi; Aamir Omair; Ismail A Khatri
Journal:  Neurosciences (Riyadh)       Date:  2021-07       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.